Hepatic Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor Levels Decline in Hepatitis C but Are Not Associated with Progression of Hepatocellular Carcinoma

Florian Weber,Kirsten Utpatel,Katja Evert,Thomas S. Weiss,Christa Buechler
DOI: https://doi.org/10.3390/biomedicines12102397
IF: 4.757
2024-10-20
Biomedicines
Abstract:Background/Objectives: Bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) is an antagonist of transforming growth factor (TGF)-β type 1 signaling [...]
biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
What problem does this paper attempt to address?